Intravitreal bevacizumab for retinopathy of prematurity: Considerations for informed consent

Kamiar Mireskandari, Megan Collins, Nasrin Tehrani

Research output: Contribution to journalArticle

Original languageEnglish (US)
Pages (from-to)409-412
Number of pages4
JournalCanadian Journal of Ophthalmology
Volume50
Issue number6
DOIs
StatePublished - Dec 1 2015

Fingerprint

Retinopathy of Prematurity
Intravitreal Injections
Angiogenesis Inhibitors
Informed Consent
Vascular Endothelial Growth Factor A
Newborn Infant
Bevacizumab

ASJC Scopus subject areas

  • Ophthalmology

Cite this

Intravitreal bevacizumab for retinopathy of prematurity : Considerations for informed consent. / Mireskandari, Kamiar; Collins, Megan; Tehrani, Nasrin.

In: Canadian Journal of Ophthalmology, Vol. 50, No. 6, 01.12.2015, p. 409-412.

Research output: Contribution to journalArticle

@article{16b66885d6af48e0a5961220f8e2348a,
title = "Intravitreal bevacizumab for retinopathy of prematurity: Considerations for informed consent",
author = "Kamiar Mireskandari and Megan Collins and Nasrin Tehrani",
year = "2015",
month = "12",
day = "1",
doi = "10.1016/j.jcjo.2015.10.004",
language = "English (US)",
volume = "50",
pages = "409--412",
journal = "Canadian Journal of Ophthalmology",
issn = "0008-4182",
publisher = "Canadian Ophthalmological Society",
number = "6",

}

TY - JOUR

T1 - Intravitreal bevacizumab for retinopathy of prematurity

T2 - Considerations for informed consent

AU - Mireskandari, Kamiar

AU - Collins, Megan

AU - Tehrani, Nasrin

PY - 2015/12/1

Y1 - 2015/12/1

UR - http://www.scopus.com/inward/record.url?scp=84951754278&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84951754278&partnerID=8YFLogxK

U2 - 10.1016/j.jcjo.2015.10.004

DO - 10.1016/j.jcjo.2015.10.004

M3 - Article

C2 - 26651298

AN - SCOPUS:84951754278

VL - 50

SP - 409

EP - 412

JO - Canadian Journal of Ophthalmology

JF - Canadian Journal of Ophthalmology

SN - 0008-4182

IS - 6

ER -